BioSpace News Archive

Genetown

Albireo Receives European Marketing Authorization of Bylvay™ (odevixibat), the First Drug Treatment for Progressive Familial Intrahepatic Cholestasis (PFIC)

Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced European Commission (EC) authorization of Bylvay (odevixibat), the first drug approved for the treatment of all subtypes of progressive familial intrahepatic cholestasis (PFIC)

July 19, 2021
·
12 min read
BioMidwest

NovaBay Pharmaceuticals Partners with Harrow Health’s ImprimisRx® to Promote Prescription Avenova

NovaBay® Pharmaceuticals, Inc., a pharmaceutical company focusing on commercializing Avenova for the eye care market, announces it has partnered with ImprimisRx, one of the nation’s leading ophthalmology-focused pharmaceutical businesses, to promote prescription Avenova.

July 19, 2021
·
7 min read
Biotech Beach

Biocept to Participate in Two July Investment Conferences

Biocept, Inc will participate at the following investment conferences: Brookline Capital Markets Newport Symposium and A.G.P.'s Virtual MedTech Summer Conference

July 19, 2021
·
1 min read
Business

Janux Therapeutics Appoints Shahram Salek-Ardakani, Ph.D., Chief Scientific Officer

Janux Therapeutics, Inc. today announced the appointment of Shahram Salek-Ardakani, Ph.D., as Chief Scientific Officer.

July 19, 2021
·
5 min read
Drug Development

Vertex Initiates Phase 2 Clinical Trial Program for VX-548 for the Treatment of Acute Pain

Vertex Pharmaceuticals Incorporated today announced that it has begun a Phase 2 proof-of-concept (POC) study in acute pain following bunionectomy surgery with the selective NaV1.8 inhibitor VX-548.

July 19, 2021
·
5 min read
Business

Xeris Pharmaceuticals Enters Into an Exclusive License and Supply Agreement with Tetris Pharma Limited to Commercialize Ogluo® in Europe

Xeris Pharmaceuticals Enters Into an Exclusive License and Supply Agreement with Tetris Pharma Limited to Commercialize Ogluo ® in Europe.

July 19, 2021
·
14 min read
Brain Mapping Pioneer Omniscient Neurotechnology Raises AUD 40 Million in Series B Financing

Omniscient Neurotechnology (“o8t™”), a pioneering brain mapping technology company, today announced the completion of an AUD 40 million Series B financing round.

July 19, 2021
·
5 min read
Biotech Bay

Cortexyme to Host Symposium at AAIC 2021

Cortexyme, Inc. announced that it will host a corporate sponsored symposium and dinner held in conjunction with the Alzheimer’s Association International Conference® 2021 (AAIC®) taking place July 26-30, 2021, in Denver, Colorado, as well as virtually.

July 19, 2021
·
5 min read
Genetown

CardioFocus to Exhibit and Present Data Supporting HeartLight X3 System at Heart Rhythm 2021

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced its participation and presence at the Heart Rhythm 2021 conference, taking place in person at the Boston Convention & Exhibition Center and virtually, July 28-31, 2021.

July 19, 2021
·
5 min read
Drug Development

G1 Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for COSELA™ (Trilaciclib) in Combination with Chemotherapy for the Treatment of Locally Advanced or Metastatic Triple Negative Breast Cancer

G1 Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to COSELA™ (trilaciclib) investigation for use in combination with chemotherapy for the treatment of locally advanced or metastatic triple negative breast cancer (TNBC).

July 19, 2021
·
5 min read